Patents by Inventor Vuong N. Trieu

Vuong N. Trieu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipid lowering quinazoline dietary supplement composition
    Patent number: 6410545
    Abstract: A novel carbonyl-substituted quinazoline, preferably 4-(3′-bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), and methods for lowering blood cholesterol, including reducing total cholesterol and LDL-cholesterol levels by administration of the carbonyl quinazolines and compositions thereof.
    Type: Grant
    Filed: June 26, 2001
    Date of Patent: June 25, 2002
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Vuong N. Trieu, Xing-Ping Liu
  • Lipid-lowering quinazoline derivative
    Patent number: 6355645
    Abstract: A novel carbonyl-substituted quinazoline, preferably 4-(3′-bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), and methods for lowering blood cholesterol, including reducing total cholesterol and LDL-cholesterol levels by administration of the carbonyl quinazolines and compositions thereof.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: March 12, 2002
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Vuong N. Trieu, Xing-Ping Liu
  • Lipid lowering quinazoline dietary supplement composition
    Publication number: 20010051629
    Abstract: A novel carbonyl-substituted quinazoline, preferably 4-(3′-bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), and methods for lowering blood cholesterol, including reducing total cholesterol and LDL-cholesterol levels by administration of the carbonyl quinazolines and compositions thereof.
    Type: Application
    Filed: June 26, 2001
    Publication date: December 13, 2001
    Applicant: Hughes Institute
    Inventors: Fatih M. Uckun, Vuong N. Trieu, Xing-Ping Liu
  • Lipid-lowering quinazoline derivative
    Publication number: 20010008894
    Abstract: A novel carbonyl-substituted quinazoline, preferably 4-(3′-bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), and methods for lowering blood cholesterol, including reducing total cholesterol and LDL-cholesterol levels by administration of the carbonyl quinazolines and compositions thereof.
    Type: Application
    Filed: March 12, 2001
    Publication date: July 19, 2001
    Applicant: Hughes Institute
    Inventors: Fatih M. Uckun, Vuong N. Trieu, Xing-Ping Liu
  • Lipid-lowering quinazoline derivative
    Patent number: 6172071
    Abstract: A novel carbonyl-substituted quinazoline, preferably 4-(3′-bromobenzoyl)-6,7-dimethoxyquinazoline (WHI-P164), and methods for lowering blood cholesterol, including reducing total cholesterol and LDL-cholesterol levels by administration of the carbonyl quinazolines and compositions thereof.
    Type: Grant
    Filed: July 30, 1998
    Date of Patent: January 9, 2001
    Assignee: Hughes Institute
    Inventors: Faith M. Uckun, Vuong N. Trieu, Xing-Ping Liu
  • EGF-isoflavone conjugates for the prevention of restenosis
    Patent number: 6034053
    Abstract: A protein conjugate containing EGF coupled to a tyrosine kinase inhibitor such as Genistein, for inhibiting or preventing restenosis following vascular injury.
    Type: Grant
    Filed: July 13, 1998
    Date of Patent: March 7, 2000
    Assignee: Wayne Hughes Institute
    Inventors: Fatih M. Uckun, Vuong N. Trieu